140 related articles for article (PubMed ID: 30011084)
21. Metastatic breast cancer induces an osteoblast inflammatory response.
Kinder M; Chislock E; Bussard KM; Shuman L; Mastro AM
Exp Cell Res; 2008 Jan; 314(1):173-83. PubMed ID: 17976581
[TBL] [Abstract][Full Text] [Related]
22. The growth arrest function of the human oncoprotein mouse double minute-2 is disabled by downstream mutation in cancer cells.
Zhou R; Frum R; Deb S; Deb SP
Cancer Res; 2005 Mar; 65(5):1839-48. PubMed ID: 15753382
[TBL] [Abstract][Full Text] [Related]
23. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation.
Bennett CN; Ouyang H; Ma YL; Zeng Q; Gerin I; Sousa KM; Lane TF; Krishnan V; Hankenson KD; MacDougald OA
J Bone Miner Res; 2007 Dec; 22(12):1924-32. PubMed ID: 17708715
[TBL] [Abstract][Full Text] [Related]
24. Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
Miller CW; Aslo A; Won A; Tan M; Lampkin B; Koeffler HP
J Cancer Res Clin Oncol; 1996; 122(9):559-65. PubMed ID: 8781571
[TBL] [Abstract][Full Text] [Related]
25. A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo.
Comiskey DF; Jacob AG; Sanford BL; Montes M; Goodwin AK; Steiner H; Matsa E; Tapia-Santos AS; Bebee TW; Grieves J; La Perle K; Boyaka P; Chandler DS
Oncogene; 2018 Jan; 37(1):95-106. PubMed ID: 28892044
[TBL] [Abstract][Full Text] [Related]
26. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype.
Erlebacher A; Derynck R
J Cell Biol; 1996 Jan; 132(1-2):195-210. PubMed ID: 8567723
[TBL] [Abstract][Full Text] [Related]
28. Bre Enhances Osteoblastic Differentiation by Promoting the Mdm2-Mediated Degradation of p53.
Jin F; Wang Y; Wang X; Wu Y; Wang X; Liu Q; Zhu Y; Liu E; Fan J; Wang Y
Stem Cells; 2017 Jul; 35(7):1760-1772. PubMed ID: 28436570
[TBL] [Abstract][Full Text] [Related]
29. Osteoblast-specific Notch2 inactivation causes increased trabecular bone mass at specific sites of the appendicular skeleton.
Yorgan T; Vollersen N; Riedel C; Jeschke A; Peters S; Busse B; Amling M; Schinke T
Bone; 2016 Jun; 87():136-46. PubMed ID: 27102824
[TBL] [Abstract][Full Text] [Related]
30. Osteoblast and osteoclast crosstalks: from OAF to Ephrin.
Tamma R; Zallone A
Inflamm Allergy Drug Targets; 2012 Jun; 11(3):196-200. PubMed ID: 22280242
[TBL] [Abstract][Full Text] [Related]
31. Genomic organization of the mouse double minute 2 gene.
Jones SN; Ansari-Lari MA; Hancock AR; Jones WJ; Gibbs RA; Donehower LA; Bradley A
Gene; 1996 Oct; 175(1-2):209-13. PubMed ID: 8917101
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis.
Jones SN; Hancock AR; Vogel H; Donehower LA; Bradley A
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15608-12. PubMed ID: 9861017
[TBL] [Abstract][Full Text] [Related]
33. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
34. Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts.
Daniele S; Giacomelli C; Pietrobono D; Barresi E; Piccarducci R; La Pietra V; Taliani S; Da Settimo F; Marinelli L; Novellino E; Martini C; Trincavelli ML
Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):737-749. PubMed ID: 30703414
[TBL] [Abstract][Full Text] [Related]
35. Mtbp haploinsufficiency in mice increases tumor metastasis.
Iwakuma T; Tochigi Y; Van Pelt CS; Caldwell LC; Terzian T; Parant JM; Chau GP; Koch JG; Eischen CM; Lozano G
Oncogene; 2008 Mar; 27(13):1813-20. PubMed ID: 17906694
[TBL] [Abstract][Full Text] [Related]
36. CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice.
Doucet M; Jayaraman S; Swenson E; Tusing B; Weber KL; Kominsky SL
J Bone Miner Res; 2016 Jul; 31(7):1381-90. PubMed ID: 26890063
[TBL] [Abstract][Full Text] [Related]
37. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.
Dela Cruz A; Grynpas MD; Mitchell J
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of Gα
Zhang L; Sugamori KS; Claridge C; Dela Cruz A; Grynpas MD; Mitchell J
J Bone Miner Res; 2017 Nov; 32(11):2171-2181. PubMed ID: 28727179
[TBL] [Abstract][Full Text] [Related]
39. Effect of extracellular calcium concentrations on osteoclast differentiation in vitro.
Shirai Y; Yoshimura Y; Yawaka Y; Hasegawa T; Kikuiri T; Takeyama S; Matsumoto A; Oguchi H
Biochem Biophys Res Commun; 1999 Nov; 265(2):484-8. PubMed ID: 10558894
[TBL] [Abstract][Full Text] [Related]
40. The transient receptor potential channel TRPV6 is dynamically expressed in bone cells but is not crucial for bone mineralization in mice.
van der Eerden BC; Weissgerber P; Fratzl-Zelman N; Olausson J; Hoenderop JG; Schreuders-Koedam M; Eijken M; Roschger P; de Vries TJ; Chiba H; Klaushofer K; Flockerzi V; Bindels RJ; Freichel M; van Leeuwen JP
J Cell Physiol; 2012 May; 227(5):1951-9. PubMed ID: 21732366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
